glp 1 for type 1 diabetes GLP-1 receptor agonists and Frontiers | GLP−1 receptor agonists

doi: 10.3389/fendo.2022.1043789 Received 14 September 2022 Accepted 21 November 2022 Published 07 December 2022 Volume 13 - 2022 Edited by Luigi Santacroce, University of Bari Aldo Moro, Italy Reviewed by Marialetizia Rastelli, Universit de Lille, France

They are not identifiable patients or guarantees of coverage

In a statement last week, Alex Schriver, a spokesperson for the group, said the Trump administration should instead focus on so-called pharmacy benefit managers (PBMs) to address high drug costs

That's a fundamentally different experience from trying to figure it out on your own

While all four belong to a class of drugs known as GLP-1 receptor agonists (with Mounjaro having dual-action as a GIP/GLP-1 agonist), each has unique features in terms of effectiveness , dosage schedule , FDA-approved uses , and suitability for different patients

To view a copy of this licence, visit About this article Cite this article Pugliese, G., de Alteriis, G., Muscogiuri, G